The usual dosage of Abecyclis is 1 tablet twice a day, as directed by your doctor. The indications for abexcelil are hormone receptor positive (HR ) and HER2-negative (HER2-) breast cancer that is advanced or has metastasized (spread to other parts of the body). It is used together with fulvestrant in women whose disease has worsened after hormone therapy for breast cancer. It is used alone in women and men with breast cancer that has worsened after hormone therapy and in breast cancer patients who have previously received chemotherapy for metastatic disease. It is used with aromatase inhibitors as first-line hormone therapy for breast cancer in postmenopausal women. The current recommended dose of abciximab in combination with fulvestrant is 150 mg orally twice daily. The recommended dose for single-agent use is 200 mg by mouth, twice a day. And during the use of the drug may cause joint pain, fatigue, nausea, vomiting, stomach pain and other adverse reactions, it is recommended to do a good job of related testing, if the situation is serious and timely discontinuation of the drug for treatment. So Abecedarian medication needs to be combined with the patient’s condition, under the guidance of the doctor.